Samir Arora Rejects Jefferies Claim SIPs Not the Cause of Rupee Weakness Millennials Hiding Years of Experience Labor Market Trends May Signal New Age Dynamics Yen Stalls as Japanese Retail Investors Hesitate in Uncertain Market Environment Ofcom Flags TikTok and YouTube as Not Safe Enough for Children Platforms Respond SpaceX Starship Test Flight Reinforces IPO Prospects Amazons Fashion Ambitions Deepen Met Gala Controversy Highlights Big Techs Growing Influence in Luxury HBANP Q1 2026 Earnings EPS Misses Estimates by 2345 Despite Positive Stock Reaction Clean Harbors Inc CLH Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Oxford Lane Capital Corp 625 Series 2027 Term Preferred Shares OXLCP Q4 2025 Earnings EPS Misses Estimates as Preferred Shares Edge Slightly Higher PM Q1 2026 Earnings EPS Surpasses Estimates by 414 Dauch Corporation Q1 2026 Earnings Stunning EPS Surprise Drives Stock Higher PDCC Q4 2025 Earnings EPS Falls Short of Estimates as Credit Market Conditions Weigh AES Corporation AES Holds Steady Near 1468 as Market Awaits Catalyst Victory Capital Holdings VCTR Holds Steady Near Resistance Key Levels to Watch Cummins CMI Posts Modest Gain as Stock Consolidates Below Resistance Osisko Development Corp ODV Drops 468 Key Support at 252 in Focus Watts Water Technologies WTS Rallies 273 as Shares Approach 310 Resistance Zone Tesla Stock Forms ThreeWeeksTight Pattern Amid Recovery From Deep Slump Telus TU Q1 2026 Earnings Solid EPS Beat Amidst Steady Operational Execution Marcus Millichap MMI Gains Real Estate Services Stock Finds Support SHFSW Surges Over 18 Warrants Trade at Crucial Support and Resistance Level Bank OZK Preferred Stock OZKAP Holds Steady Near Support as Trading Activity Remains Subdued Monte Rosa Therapeutics GLUE Edges Lower Holding Near Key Support Level GMEX Robotics Gains 437 Testing Resistance After Support Bounce Everest Group Ltd EG Holds Steady Near 353 as Insurance Sector Shows Mixed Signals Stag Industrial STAG Edges Higher Testing Key Resistance After Modest Gain Akebia Therapeutics AKBA Holds Steady at 102 as Stock Consolidates Near Key Support